SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
SERA PROGNOSTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.03−0.03 (-1.46%)
Close on Oct 19, 2026
- Market cap
- $102.47M
- P/E (TTM)
- –
- Dividend yield
- –
Sera Prognostics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison
Valuation
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Market Cap | $80.08M | $1.11B |
| Enterprise Value | $33.64M | $1.41B |
| PS Ratio | 1144.03 | 1.60 |
| PB Ratio | 1.35 | 3.03 |
| P/TBV Ratio | 1.37 | 4.99 |
Enterprise value
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| EV / Sales | 480.54 | 1.69 |
Income (trailing twelve months)
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Revenue | $70.00K | $561.90M |
| Gross Profit | -$105.00K | $173.32M |
| Operating Income | -$37.30M | -$1.81M |
| Net Income | -$33.23M | -$1.16M |
| EBITDA | -$36.49M | -$20.72K |
| EPS (Diluted) | -$0.67 | -$0.02 |
Margins
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Gross Margin | -150.0% | 33.1% |
| Operating Margin | -53282.9% | -4.45% |
| Profit Margin | -47475.7% | -2.91% |
| EBITDA Margin | -52121.4% | 2.41% |
| FCF Margin | -40211.4% | 3.13% |
Returns
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -45.0% | 1.84% |
| Return on Assets (ROA) | -33.5% | -3.06% |
| Return on Invested Capital (ROIC) | -96.6% | 2.11% |
| Return on Capital Employed (ROCE) | -59.8% | -0.57% |
Growth
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -35.2% | 6.92% |
| Revenue Growth (3Y CAGR) | -32.9% | 10.9% |
| Revenue Growth (5Y CAGR) | 26.5% | 13.2% |
Balance sheet
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $46.45M | $48.71M |
| Net Cash (Debt) | $46.45M | $205.49K |
| Net Cash Per Share | $1.18 | $0.01 |
| Equity (Book Value) | $59.38M | $235.16M |
| Book Value Per Share | $1.51 | $3.48 |
| Tangible Book Value | $58.49M | $703.69K |
| Working Capital | $23.78M | $30.48M |
Financial position
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Current Ratio | 1.98 | 1.40 |
| Quick Ratio | 1.91 | 1.02 |
| Interest Coverage | -5328.29 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Operating Cash Flow | -$27.68M | $3.10M |
| Capital Expenditures | -$466.00K | -$18.62M |
| Free Cash Flow | -$28.15M | $23.73M |
| FCF Per Share | -$0.71 | $0.37 |
Efficiency
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.87 |
Dividends and yields
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Earnings Yield | -41.5% | -0.59% |
| FCF Yield | -35.1% | 1.74% |
| Buyback Yield | 0.00% | 0.32% |
| Shareholder Yield | 0.00% | 0.65% |
Shares
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Shares Outstanding | 39,449,500 | 58,282,400 |
| Shares Change (YoY) | 26.3% | 2.68% |
| Float | 27,441,900 | 33,780,100 |
| Shares Held by Insiders | 30.4% | 16.4% |
| Shares Held by Institutions | 43.2% | 85.9% |
Scores
| Measure | Sera Prognostics | Industry median |
|---|---|---|
| Altman Z-Score | -4.65 | 2.05 |
| Piotroski F-Score | 4 | 5 |
| Beneish M-Score | -3.42 | -2.71 |
Calculated by StockData from Sera Prognostics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.